Description

Semaglutide Glu17 impurity is a high-purity impurity reference standard designed for pharmaceutical quality control, analytical method development, and regulatory compliance testing of Semaglutide. In this variant, the glutamine residue at position 17 is converted to glutamic acid by deamidation, one of the most common chemical degradation pathways of Gln-containing peptides. This reference material supports accurate impurity identification, structural confirmation, and quantitative analysis by HPLC and LC-MS in peptide drug development and manufacturing workflows.

Specifications

Parameter	Value
API Category	Semaglutide Impurity
Appearance	Off-white lyophilized powder
Catalog Number	BF-SMG-Glu17
Package Size	50 mg (custom sizes available upon request)
Purity	≥95% (HPLC)
Salt Form	Sodium salt
CAS Number	N/A
Molecular Formula	N/A
Molecular Weight	N/A
Solubility	20% ACN in water
Storage Condition	-20±5°C, protect from light and moisture
Synonyms	[Glu17]Semaglutide; Deamidation impurity

Applications

Pharmaceutical impurity profiling and quality control
HPLC and LC-MS/MS method development and validation
Drug substance and drug product release testing
Stability studies and forced degradation analysis
Regulatory submission support (FDA, EMA, ICH guidelines)

Custom sizes and specifications are available upon request. Please use the Request a Quote button for pricing.

For research use only. Not intended for diagnostic or therapeutic use.

Documents

MSDS

COA

Semaglutide Glu17 Impurity Reference Standard